Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer

J Radiat Res. 2015 Jan;56(1):159-68. doi: 10.1093/jrr/rru093. Epub 2014 Oct 26.

Abstract

This retrospective analysis focusses on the impact of therapy on perceived long-term post-cancer treatment function. A validated questionnaire including items and components for the assessment of communicative ability, quality of voice and swallowing was sent to 129 patients. All patients were treated between 1998 and 2007. A total of 76 patients (58.9%) with carcinoma of the larynx or hypopharynx replied to the questionnaire. Data was evaluated retrospectively. Therapy delivered was definitive radio(chemo)therapy (defchRT/RT) (21/76, 28%), laryngectomy + radio(chemo)therapy (LE + chRT/RT) (28/76, 37%), or larynx conservation surgery + radio(chemo)therapy (LCS + chRT/RT) (27/76, 36%). Radiotherapy was administered using 2D- or 3D-conformal planning. The most common concomitant chemotherapy delivered was cisplatin + 5FU. For statistical analyses of the components, averages were calculated and tested using the Kruskal-Wallis test and the U-test of Mann and Whitney. Differences were assessed by the Monte Carlo method or Fisher's exact test. The single item rates were compared with Fisher's exact test. Mean follow-up was 56.7 months (range, 8-130 months). After defchRT/RT, patients trended towards more substantial-strong hoarseness compared with LCS + chRT/RT (P = 0.2). After LE, patients were dissatisfied with their artificial larynx/electrolarynx and the tone of their voice (P = 0.3, P = 0.07) and communicative ability (P = 0.005, P = 0.008) compared with those treated with defchRT/RT and LCS + chRT/RT, respectively. Dysphagia and additional percutaneous endoscopic gastrostomy (PEG) feeding were more frequent after defchRT/RT in comparison with the other two groups (P < 0.05). Voice quality and communicative ability were slightly worse after defchRT/RT and LE + chRT/RT, but satisfying with all treatment modalities. Further development of the therapy approach is necessary to reduce long-term side effects, with measures of post-treatment function as important endpoints.

Keywords: dysphagia; quality of voice; radiation; surgery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Chemoradiotherapy / adverse effects*
  • Combined Modality Therapy / methods
  • Deglutition
  • Deglutition Disorders / etiology*
  • Deglutition Disorders / psychology
  • Female
  • Hoarseness / etiology*
  • Hoarseness / psychology
  • Humans
  • Hypopharyngeal Neoplasms / psychology
  • Hypopharyngeal Neoplasms / therapy*
  • Laryngeal Neoplasms / psychology
  • Laryngeal Neoplasms / therapy*
  • Laryngectomy*
  • Larynx / radiation effects
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Organ Sparing Treatments / methods
  • Organ Sparing Treatments / psychology
  • Patient Satisfaction
  • Radiation Injuries / etiology
  • Radiation Injuries / psychology
  • Retrospective Studies
  • Treatment Outcome
  • Voice Quality